Disease-information
Baricitinib plus remdesivir was superior to remdesivir alone in reducing
recovery time and accelerating improvement in clinical status among
patients with Covid-19, notably among those receiving high-flow oxygen
or noninvasive ventilation. The combination was associated with fewer
serious adverse events.
The U.S. Food and Drug
Administration issued an emergency use authorization (EUA) for the drug
baricitinib, in combination with remdesivir, for the treatment of suspected or
laboratory confirmed COVID-19 in hospitalized adults and pediatric patients two
years of age or older requiring supplemental oxygen, invasive mechanical...
National guidelines version 8th on clinical management of Coronavirus
disease by Disease Control Division, Directorate General of Health
Services, Ministry of Health & Family Welfare & Government of the
People's Republic of Bangladesh.
The guideline includes clinical management of COVID-19 and
is updated with the latest evide...
National guidelines version 8th on clinical management of Coronavirus
disease by Disease Control Division, Directorate General of Health
Services, Ministry of Health & Family Welfare & Government of the
People's Republic of Bangladesh.
The guideline includes clinical management of COVID-19 and
is updated with the latest evide...
An Aid to the Management of
COVID-19 in Bangladesh: “Lessons from the western experience” New 5th Edition
This book is a small effort by
some highly-motivated Bangladeshi doctors living in the UK and the USA to
supplement local guidelines in Bangladesh. This will hopefully enable local
experts in Bangladesh to be kept updated...
An Aid to the Management of
COVID-19 in Bangladesh: “Lessons from the western experience” New 5th Edition
This book is a small effort by
some highly-motivated Bangladeshi doctors living in the UK and the USA to
supplement local guidelines in Bangladesh. This will hopefully enable local
experts in Bangladesh to be kept updated...
National guidelines on clinical management of Coronavirus disease by Disease Control Division, Directorate General of Health Services, Ministry of Health & Family Welfare & Government of the People's Republic of Bangladesh.The guideline includes clinical management of COVID-19 and is updated with the latest evidence and the WHO guidelines.
National guidelines on clinical management of Coronavirus disease by Disease Control Division, Directorate General of Health Services, Ministry of Health & Family Welfare & Government of the People's Republic of Bangladesh.The guideline includes clinical management of COVID-19 and is updated with the latest evidence and the WHO guidelines.
Comparative study of PPI for symptom
relief in patients with reflux esophagitis:
Some of the present study demonstrated
that esomeprazole gave faster symptom relief than pantoprazole, lansoprazole
and omeprazole.
Because:
Esomeprazole has been shown to have a
faster onset of anti-secretory...
The 2017 ACC/AHA guidelines
eliminate the (JNC 7) classification of prehypertension and divides it into two levels:
Elevated blood pressure with a systolic pressure
between 120 and 129 mm Hg and diastolic pressure less than 80 mm Hg
Stage 1 hypertension, with a systolic pressure of 130
to 139 mm Hg or a diastoli...
